Page 103 - Quantitative Imaging of Small Tumours with Positron Emission Tomography

Chapter 4 22. Jauw YWS, Heijtel DF, Zijlstra JM, et al. Noise-Induced Variability of Immuno-PET with Zirconium- 89-Labeled Antibodies: an Analysis Based on Count-Reduced Clinical Images. Mol Imaging Biol. 2018;20:1025-1034. 23. Frings V, van Velden FH, Velasquez LM, et al. Repeatability of metabolically active tumor volume measurements with FDG PET/CT in advanced gastrointestinal malignancies: a multicenter study. Radiology. 2014;273:539-548. 24. Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet. 1986;1:307-310. 25. Koo TK, Li MY. A Guideline of Selecting and Reporting Intraclass Correlation Coefficients for Reliability Research. J Chiropr Med. 2016;15:155-163. 26. Wilcox RR. Comparing the Variances of Dependent Groups. Psychometrika. 1989;54:305-315. 27. Oprea-Lager DE, Kramer G, van de Ven PM, et al. Repeatability of Quantitative 18F-Fluoromethylcholine PET/CT Studies in Prostate Cancer. J Nucl Med. 2016;57:721-727. 28. Lodge MA. Repeatability of SUV in Oncologic (18)F-FDG PET. J Nucl Med. 2017;58:523-532. 29. Kramer GM, Liu Y, de Langen AJ, et al. Repeatability of quantitative (18)F-FLT uptake measurements in solid tumors: an individual patient data multi-center meta-analysis. Eur J Nucl Med Mol Imaging. 2018;45:951-961. 30. Wahl RL, Jacene H, Kasamon Y, Lodge MA. From RECIST to PERCIST: Evolving Considerations for PET response criteria in solid tumors. J Nucl Med. 2009;50 Suppl 1:122S-150S. 31. Soret M, Bacharach SL, Buvat I. Partial-volume effect in PET tumor imaging. J Nucl Med. 2007;48:932- 945. 32. Rahmim A, Tang J. Noise propagation in resolution modeled PET imaging and its impact on detectability. Physics in Medicine and Biology. 2013;58:6945-6968. 33. Devriese J, Beels L, Maes A, Van de Wiele C, Pottel H. Impact of PET reconstruction protocols on quantification of lesions that fulfil the PERCIST lesion inclusion criteria. EJNMMI Phys. 2018;5:35. 34. Quak E, Le Roux PY, Hofman MS, et al. Harmonizing FDG PET quantification while maintaining optimal lesion detection: prospective multicentre validation in 517 oncology patients. Eur J Nucl Med Mol Imaging. 2015;42:2072-2082. 102